4//SEC Filing
FORMELA JEAN FRANCOIS 4
Accession 0001209191-22-037598
CIK 0001652130other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 6:33 PM ET
Size
7.9 KB
Accession
0001209191-22-037598
Insider Transaction Report
Form 4
FORMELA JEAN FRANCOIS
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-14+7,688→ 7,688 totalExercise: $38.49Exp: 2032-06-13→ Common Stock (7,688 underlying) - Award
Common Stock
2022-06-14+5,197→ 7,291 total
Footnotes (3)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]This option was granted on June 14, 2022 with respect to 7,688 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.
- [F3]The reporting person is a member of Atlas Venture Associates IX, LLC ("AVA IX LLC") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to Atlas Venture Advisors, L.P. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001030575
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 6:33 PM ET
- Size
- 7.9 KB